cat |
LDLo |
intravenous |
30mg/kg (30mg/kg) |
SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE
GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS
GASTROINTESTINAL: NAUSEA OR VOMITING |
Journal of Pharmacology and Experimental Therapeutics. Vol. 128, Pg. 7, 1960. |
cat |
LDLo |
subcutaneous |
30mg/kg (30mg/kg) |
SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE
GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS
GASTROINTESTINAL: NAUSEA OR VOMITING |
Journal of Pharmacology and Experimental Therapeutics. Vol. 128, Pg. 7, 1960. |
man |
TDLo |
unreported |
117mg/kg/2.5Y (117mg/kg) |
SENSE ORGANS AND SPECIAL SENSES: VISUAL FIELD CHANGES: EYE
SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE |
British Medical Journal. Vol. 1, Pg. 331, 1963. |
mouse |
LD50 |
intraperitoneal |
48mg/kg (48mg/kg) |
BEHAVIORAL: ANTICONVULSANT |
Japanese Journal of Pharmacology. Vol. 13, Pg. 186, 1963. |
mouse |
LD50 |
intravenous |
12100ug/kg (12.1mg/kg) |
|
Arzneimittel-Forschung. Drug Research. Vol. 12, Pg. 352, 1962. |
mouse |
LD50 |
oral |
121mg/kg (121mg/kg) |
|
Archives Internationales de Pharmacodynamie et de Therapie. Vol. 166, Pg. 449, 1967. |
mouse |
LD50 |
subcutaneous |
95mg/kg (95mg/kg) |
|
Annals of the New York Academy of Sciences. Vol. 80, Pg. 568, 1959. |
rat |
LD50 |
intraperitoneal |
40mg/kg (40mg/kg) |
|
"Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 353, 1972. |
rat |
LD50 |
intravenous |
44mg/kg (44mg/kg) |
|
"Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 353, 1972. |
rat |
LD50 |
oral |
34mg/kg (34mg/kg) |
|
"Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 353, 1972. |
rat |
LD50 |
subcutaneous |
45mg/kg (45mg/kg) |
|
"Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 353, 1972. |